Literature DB >> 30548593

Willingness to Change Medications Linked to Increased Fall Risk: A Comparison between Age Groups.

Yara K Haddad1, Mamta V Karani2, Gwen Bergen3, Zachary A Marcum4.   

Abstract

OBJECTIVE: To describe and compare two age groups' knowledge of medications linked to falls and willingness to change these medications to reduce their fall risk.
METHOD: We analyzed data from community-dwelling adults age 55 and older (n = 1812): 855 adults aged 55 to 64 years and 957 older adults (65 and older) who participated in the 2016 summer wave of the ConsumerStyles survey, an annual Web-based survey. The data are weighted to match the US Current Population Survey proportions on nine US Census Bureau demographic characteristics. MEASUREMENTS: Survey respondents were asked about medication use, knowledge of side effects, their willingness to change their medications to reduce fall risk, communication in the previous year about fall risk with their healthcare provider, and their comfort in discussing fall risk with their healthcare provider. All data were weighted to match the 2016 population estimates. Descriptive statistics and χ2 (p ≤ .05) were used to identify differences between the two age groups.
RESULTS: About one-fifth of all respondents reported using at least one class of medication that increases fall risk. Older adults were less likely to report using medications for mood or sadness, less likely to report knowing the side effects of pain medications, and more willing to change their sleep medications compared with their younger counterparts. Among all respondents using these medication classes, less than one-third knew the potential fall-related side effects. However, most of them expressed willingness to change their medication if advised by their healthcare provider.
CONCLUSION: Most older adults were unaware of potential fall risks associated with medications prescribed to address pain, difficulty sleeping, mood or sadness, and anxiety- or nervousness-related health issues. However, most were willing to change their medication if recommended by a healthcare provider. J Am Geriatr Soc 67:527-533, 2019. Published 2018 This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  elderly; falls; medications; older adults

Mesh:

Substances:

Year:  2018        PMID: 30548593      PMCID: PMC6647846          DOI: 10.1111/jgs.15696

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  27 in total

1.  Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2001-05       Impact factor: 5.562

Review 2.  Falls in older people: epidemiology, risk factors and strategies for prevention.

Authors:  Laurence Z Rubenstein
Journal:  Age Ageing       Date:  2006-09       Impact factor: 10.668

3.  The elderly--a challenge for appropriate drug treatment.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-03       Impact factor: 2.953

4.  Development and testing of a short form of the patient activation measure.

Authors:  Judith H Hibbard; Eldon R Mahoney; Jean Stockard; Martin Tusler
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

5.  Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions.

Authors:  Terri R Fried; Mary E Tinetti; Lynne Iannone
Journal:  Arch Intern Med       Date:  2010-09-13

6.  Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial.

Authors:  A J Campbell; M C Robertson; M M Gardner; R N Norton; D M Buchner
Journal:  J Am Geriatr Soc       Date:  1999-07       Impact factor: 5.562

7.  Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study.

Authors:  Francesco Landi; Graziano Onder; Matteo Cesari; Christian Barillaro; Andrea Russo; Roberto Bernabei
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-05       Impact factor: 6.053

8.  Qualitative insights into general practitioners views on polypharmacy.

Authors:  Sibyl Anthierens; Anneleen Tansens; Mirko Petrovic; Thierry Christiaens
Journal:  BMC Fam Pract       Date:  2010-09-15       Impact factor: 2.497

9.  Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers.

Authors:  Judith H Hibbard; Jean Stockard; Eldon R Mahoney; Martin Tusler
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

10.  Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study.

Authors:  Rollin M Wright; Yazan F Roumani; Robert Boudreau; Anne B Newman; Christine M Ruby; Stephanie A Studenski; Ronald I Shorr; Douglas C Bauer; Eleanor M Simonsick; Sarah N Hilmer; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2009-02       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.